Published date: 22 July 2021
This notice was replaced on 22 July 2021
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Opportunity (published 22 July 2021, last edited 6 August 2021)
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
Pharmaceutical products - 33600000
Various medicinal products - 33690000
Location of contract
England
Value of contract
£3,185,000,000
Procurement reference
CF-0272200D0O000000rwimUAA1
Published date
22 July 2021
Closing date
3 September 2021
Closing time
1pm
Contract start date
1 November 2021
Contract end date
31 March 2024
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
NHS Framework Agreement for the supply of Direct Oral Anticoagulants (DOACs) for the NHS in England. Also known as Novel Oral Anticoagulants (NOACs).
Period of Framework: 01/11/2021 - 31/04/2024 with an option to extend (at the Authority's discretion) for a further period (or periods) up to a total of 12 months (i.e. total possible framework duration of 41 months)
All documents can be found at https://health.atamis.co.uk/. Atamis Reference Number: C40079
About the buyer
Contact name
Gero Lo Manto
Address
80 London Road
London
SE1 6LH
GB
Share this notice
All content is available under the
